209 related articles for article (PubMed ID: 22892349)
1. Increased binding of peripheral benzodiazepine receptor in mild cognitive impairment-dementia converters measured by positron emission tomography with [¹¹C]DAA1106.
Yasuno F; Kosaka J; Ota M; Higuchi M; Ito H; Fujimura Y; Nozaki S; Takahashi S; Mizukami K; Asada T; Suhara T
Psychiatry Res; 2012 Jul; 203(1):67-74. PubMed ID: 22892349
[TBL] [Abstract][Full Text] [Related]
2. Increased binding of peripheral benzodiazepine receptor in Alzheimer's disease measured by positron emission tomography with [11C]DAA1106.
Yasuno F; Ota M; Kosaka J; Ito H; Higuchi M; Doronbekov TK; Nozaki S; Fujimura Y; Koeda M; Asada T; Suhara T
Biol Psychiatry; 2008 Nov; 64(10):835-41. PubMed ID: 18514164
[TBL] [Abstract][Full Text] [Related]
3. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R
J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation.
Venneti S; Lopresti BJ; Wang G; Slagel SL; Mason NS; Mathis CA; Fischer ML; Larsen NJ; Mortimer AD; Hastings TG; Smith AD; Zigmond MJ; Suhara T; Higuchi M; Wiley CA
J Neurochem; 2007 Sep; 102(6):2118-2131. PubMed ID: 17555551
[TBL] [Abstract][Full Text] [Related]
5. A comparative autoradiography study in post mortem whole hemisphere human brain slices taken from Alzheimer patients and age-matched controls using two radiolabelled DAA1106 analogues with high affinity to the peripheral benzodiazepine receptor (PBR) system.
Gulyás B; Makkai B; Kása P; Gulya K; Bakota L; Várszegi S; Beliczai Z; Andersson J; Csiba L; Thiele A; Dyrks T; Suhara T; Suzuki K; Higuchi M; Halldin C
Neurochem Int; 2009 Jan; 54(1):28-36. PubMed ID: 18984021
[TBL] [Abstract][Full Text] [Related]
6. The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders.
Venneti S; Wang G; Nguyen J; Wiley CA
J Neuropathol Exp Neurol; 2008 Oct; 67(10):1001-10. PubMed ID: 18800007
[TBL] [Abstract][Full Text] [Related]
7. Age and disease related changes in the translocator protein (TSPO) system in the human brain: positron emission tomography measurements with [11C]vinpocetine.
Gulyás B; Vas A; Tóth M; Takano A; Varrone A; Cselényi Z; Schain M; Mattsson P; Halldin C
Neuroimage; 2011 Jun; 56(3):1111-21. PubMed ID: 21320609
[TBL] [Abstract][Full Text] [Related]
8. The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds specifically to microglia in a rat model of traumatic brain injury: implications for PET imaging.
Venneti S; Wagner AK; Wang G; Slagel SL; Chen X; Lopresti BJ; Mathis CA; Wiley CA
Exp Neurol; 2007 Sep; 207(1):118-27. PubMed ID: 17658516
[TBL] [Abstract][Full Text] [Related]
9. Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia.
Olsson B; Hertze J; Lautner R; Zetterberg H; Nägga K; Höglund K; Basun H; Annas P; Lannfelt L; Andreasen N; Minthon L; Blennow K; Hansson O
J Alzheimers Dis; 2013; 33(1):45-53. PubMed ID: 22890100
[TBL] [Abstract][Full Text] [Related]
10. Microglial activation in Alzheimer's disease: an (R)-[¹¹C]PK11195 positron emission tomography study.
Schuitemaker A; Kropholler MA; Boellaard R; van der Flier WM; Kloet RW; van der Doef TF; Knol DL; Windhorst AD; Luurtsema G; Barkhof F; Jonker C; Lammertsma AA; Scheltens P; van Berckel BN
Neurobiol Aging; 2013 Jan; 34(1):128-36. PubMed ID: 22840559
[TBL] [Abstract][Full Text] [Related]
11. Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia.
Cerami C; Della Rosa PA; Magnani G; Santangelo R; Marcone A; Cappa SF; Perani D
Neuroimage Clin; 2015; 7():187-94. PubMed ID: 25610780
[TBL] [Abstract][Full Text] [Related]
12. Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [
Brody AL; Hubert R; Enoki R; Garcia LY; Mamoun MS; Okita K; London ED; Nurmi EL; Seaman LC; Mandelkern MA
Neuropsychopharmacology; 2017 Jul; 42(8):1630-1639. PubMed ID: 28262740
[TBL] [Abstract][Full Text] [Related]
13. Effect of overnight smoking abstinence on a marker for microglial activation: a [
Brody AL; Gehlbach D; Garcia LY; Enoki R; Hoh C; Vera D; Kotta KK; London ED; Okita K; Nurmi EL; Seaman LC; Mandelkern MA
Psychopharmacology (Berl); 2018 Dec; 235(12):3525-3534. PubMed ID: 30343364
[TBL] [Abstract][Full Text] [Related]
14. Increased Plasma Beta-Secretase 1 May Predict Conversion to Alzheimer's Disease Dementia in Individuals With Mild Cognitive Impairment.
Shen Y; Wang H; Sun Q; Yao H; Keegan AP; Mullan M; Wilson J; Lista S; Leyhe T; Laske C; Rujescu D; Levey A; Wallin A; Blennow K; Li R; Hampel H
Biol Psychiatry; 2018 Mar; 83(5):447-455. PubMed ID: 28359566
[TBL] [Abstract][Full Text] [Related]
15. Neuroinflammation in mild cognitive impairment and Alzheimer's disease: A meta-analysis.
Bradburn S; Murgatroyd C; Ray N
Ageing Res Rev; 2019 Mar; 50():1-8. PubMed ID: 30610927
[TBL] [Abstract][Full Text] [Related]
16. A modified method of 3D-SSP analysis for amyloid PET imaging using [¹¹C]BF-227.
Kaneta T; Okamura N; Minoshima S; Furukawa K; Tashiro M; Furumoto S; Iwata R; Fukuda H; Takahashi S; Yanai K; Kudo Y; Arai H
Ann Nucl Med; 2011 Dec; 25(10):732-9. PubMed ID: 21792587
[TBL] [Abstract][Full Text] [Related]
17. Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging.
Hamelin L; Lagarde J; Dorothée G; Leroy C; Labit M; Comley RA; de Souza LC; Corne H; Dauphinot L; Bertoux M; Dubois B; Gervais P; Colliot O; Potier MC; Bottlaender M; Sarazin M;
Brain; 2016 Apr; 139(Pt 4):1252-64. PubMed ID: 26984188
[TBL] [Abstract][Full Text] [Related]
18. Brain Metabolism and Microglia Activation in Mild Cognitive Impairment: A Combined [18F]FDG and [11C]-(R)-PK11195 PET Study.
Tondo G; Boccalini C; Caminiti SP; Presotto L; Filippi M; Magnani G; Frisoni GB; Iannaccone S; Perani D
J Alzheimers Dis; 2021; 80(1):433-445. PubMed ID: 33579848
[TBL] [Abstract][Full Text] [Related]
19. The Alzheimer's disease metabolic brain pattern in mild cognitive impairment.
Meles SK; Pagani M; Arnaldi D; De Carli F; Dessi B; Morbelli S; Sambuceti G; Jonsson C; Leenders KL; Nobili F
J Cereb Blood Flow Metab; 2017 Dec; 37(12):3643-3648. PubMed ID: 28929833
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F
Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
